Detalles de la búsqueda
1.
Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I.
Bioorg Med Chem
; 23(10): 2568-78, 2015 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25862209
2.
Highly potent and orally active CCR5 antagonists as anti-HIV-1 agents: synthesis and biological activities of 1-benzazocine derivatives containing a sulfoxide moiety.
J Med Chem
; 49(6): 2037-48, 2006 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-16539392
3.
Novel, non-acylguanidine-type Na(+)/H(+) exchanger inhibitors: synthesis and pharmacology of 5-tetrahydroquinolinylidene aminoguanidine derivatives.
J Med Chem
; 45(14): 3009-21, 2002 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-12086486
4.
In vitro and in vivo pharmacology of a structurally novel Na+-H+ exchange inhibitor, T-162559.
Br J Pharmacol
; 135(8): 1995-2003, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11959803
5.
TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans.
Antimicrob Agents Chemother
; 49(11): 4584-91, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16251299
6.
Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety.
Bioorg Med Chem
; 13(2): 363-86, 2005 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-15598559
7.
Synthesis of 1-benzothiepine and 1-benzazepine derivatives as orally active CCR5 antagonists.
Chem Pharm Bull (Tokyo)
; 52(2): 254-8, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14758013
8.
Orally active CCR5 antagonists as anti-HIV-1 agents 2: synthesis and biological activities of anilide derivatives containing a pyridine N-oxide moiety.
Chem Pharm Bull (Tokyo)
; 52(7): 818-29, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15256702
9.
Orally active CCR5 antagonists as anti-HIV-1 agents: synthesis and biological activity of 1-benzothiepine 1,1-dioxide and 1-benzazepine derivatives containing a tertiary amine moiety.
Chem Pharm Bull (Tokyo)
; 52(5): 577-90, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15133211
Resultados
1 -
9
de 9
1
Próxima >
>>